Navigation Links
EpiCast Report: Systemic Lupus Erythematosus Epidemiology Forecast to 2022
Date:11/19/2013

London (PRWEB) November 19, 2013

EpiCast Report: Systemic Lupus Erythematosus Epidemiology Forecast to 2022

Summary

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease of multifactorial origin that can affect any organ or organ systems, resulting in a broad spectrum of clinical manifestations ranging from dermatological involvement to multi-organ failure with episodes of relapses and remissions. The disease has unpredictable natural course and high rates of morbidity and death The incidence and prevalence of SLE varies globally and the variation is attributed to a combination of elements such as the characteristics of the population studied, sex, ethnicity, geographical locations, occupational factors, familial traits, time period involved, and the diagnostic criteria used. Lupus nephritis (LN) or lupus glomerulonephritis is a serious complication of SLE in which the kidneys are affected.

GlobalData epidemiologists utilized data from country-specific studies published in peer-reviewed journals and governmental documents to provide the age- and sex-specific prevalent cases of diagnosed SLE in the respective markets. The forecast methodology and disease diagnosis criteria were consistent across all of the 7MM to allow for a meaningful comparison among them. The SLE prevalent case forecast followed the 1982 American College of Rheumatology classification and the LN cases were segmented according to the WHO 1982 classification.

The report forecast that 2012 had 452,053 diagnosed prevalent cases of SLE in the 7MM, with approximately 60% of the diagnosed prevalent cases (265,562) in the US alone. GlobalData epidemiologists forecast that there will be 488,769 diagnosed prevalent cases of SLE in the 7MM by 2022, with an overall average annual growth rate (AGR) of 0.81% during the forecast period. GlobalData’s epidemiological forecast projected an increase in the diagnosed prevalent cases.

Scope

-The Systemic Lupus Erythematosus (SLE) EpiCast Report provides an overview of the risk factors and global trends for SLE for the seven major markets (7MM; US, France, Germany, Italy, Spain, UK, and Japan). GlobalData epidemiologists provide the 10-year epidemiological forecast of the diagnosed prevalent cases of SLE segmented by sex and age and the diagnosed prevalent cases of lupus nephritis (LN) for the 7MM. The prevalent cases of LN in the US, France, Germany, Italy, Spain, and UK are further segmented by severity class (Class I–VI). The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

The Systemic Lupus Erythematosus EpiCast report will allow you to -
-Develop business strategies by understanding the trends shaping and driving the global SLE market.
-Quantify patient populations in the global SLE to improve product design, pricing, and launch plans.
-Organize sales and marketing efforts by identifying the age groups, sex, and LN class that present the best opportunities for SLE therapeutics in each of the markets covered.
-Identify the percentage of LN prevalent cases in each severity class.

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 6
2 Introduction 7
2.1 Catalyst 7
3 Epidemiology 8
3.1 Disease Background 8
3.2 Risk Factors and Comorbidities 10
3.2.1 Women are at a higher risk of developing SLE than men 11
3.2.2 Caucasians are at lower risk of developing SLE than other ethnicities 12
3.2.3 Familial history has been associated with an increased risk of developing SLE 13
3.2.4 Certain occupational and environmental exposures trigger SLE 14
3.3 Global Trends 15
3.3.1 US 16
3.3.2 5EU 17
3.3.3 Japan 20
3.4 Forecast Methodology 20
3.4.1 Sources Used 23
3.4.2 Sources Not Used 27
3.4.3 Forecast Assumptions and Methods 28
3.5 Epidemiological Forecast of SLE (2012–2022) 34
3.5.1 Diagnosed Prevalent Cases of SLE 34
3.5.2 Age-Specific Prevalent Cases of SLE 36
3.5.3 Sex-Specific Prevalent Cases of Diagnosed SLE 38
3.5.4 Age-Standardized Prevalence of SLE 40
3.5.5 Diagnosed Prevalent Cases of LN 41
3.5.6 Prevalent Cases of LN, Segmented by Class 43
3.6 Discussion 45
3.6.1 Conclusions on Epidemiology Trends 45
3.6.2 Limitations of the Analysis 46
3.6.3 Strengths of the Analysis 47
4 Appendix 49
4.1 Bibliography 49
4.2 About the Authors 54
4.2.1 Epidemiologist 54
4.2.2 Reviewers 54
4.2.3 Global Director of Epidemiology and Health Policy 56
4.2.4 Global Head of Healthcare 56
4.3 About GlobalData 57
4.4 About EpiCast 57
4.5 Disclaimer 58

1.1 List of Tables

Table 1: The 1982 Revised ARC Criteria For Classification of Systemic Lupus Erythematosus 9
Table 2: Risk Factors Associated with SLE 10
Table 3: World Health Organization Morphologic Classification of Lupus Nephritis (Modified in 1982) 21
Table 4: Sources of Prevalence Data Used in this Analysis 22
Table 5: 7MM, Prevalent Cases of Diagnosed SLE, All Ages, Both Sexes, N, Select Years 2012–2022 35
Table 6: 7MM, Prevalent Cases of Diagnosed SLE, by Age, Both Sexes, N, Row (%), 2012 37
Table 7: 7MM, Prevalent Cases of Diagnosed SLE, All Ages, by Sex, N, Row (%), 2012 38
Table 8: 7MM, Prevalent Cases of Diagnosed LN, All Ages, Both Sexes, N, Select Years 2012–2022 42
Table 9: 6MM, Prevalent Cases in the Different Classes of LN, All Age, Both Sexes, N, Row (%), 2012 43

1.2 List of Figures

Figure 1: 7MM, Prevalent Cases of Diagnosed SLE, All Ages, Both Sexes, N, 2012–2022 35
Figure 2: 7MM, Prevalent Cases of Diagnosed SLE, by Age, Both Sexes, N, Row (%), 2012 37
Figure 3: 7MM, Prevalent Cases of Diagnosed SLE, All Ages, Both Sexes, 2012 39
Figure 4: 7MM, Age-Standardized Prevalence (%) of Diagnosed SLE, All Ages, by Sex, 2012 40
Figure 5: 7MM, Prevalent Cases of Diagnosed LN, All Ages, Both Sexes, N, 2012–2022 42
Figure 6: 6MM, Prevalent Cases of LN, by Class, All Ages, Both Sexes, 2012 44

Read the full report:

EpiCast Report: Systemic Lupus Erythematosus Epidemiology Forecast to 2022

http://www.reportbuyer.com/pharma_healthcare/diseases/epicast_report_systemic_lupus_erythematosus_epidemiology_forecast_2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: http://www.reportbuyer.com

Read the full story at http://www.prweb.com/releases/2013/11/prweb11349155.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. EpiCast Report: Pancreatic Cancer - Epidemiology Forecast to 2022
2. Report: Strategies to prevent noise-induced hearing loss, tinnitus in soldiers
3. New report: The ACAS PCIP serving as a bridge; High-risk pools not a long-term solution
4. Report: Cancer now leading cause of death in US hispanics
5. Report: 39 States on Pace for Obesity Rates Above 50%
6. New report: Employer health insurance premiums increased 62 percent from 2003 to 2011
7. New report: State action on Affordable Care Acts 2014 health insurance market reforms
8. Federal NuvaRing Blood-Clotting Lawsuits Report: Resource4thePeople Updates Consumers with News That First Bellwether Trial Rescheduled to July
9. Report: Communications technology among tools needed to aid miner safety
10. Register to download Merrill DataSite's report: Monthly M&A Insider, March 2013
11. Download Merrill DataSite's Report: Best Practices of the Best M&A Dealmakers - Opportunity & Risk: Uncovering and Winning the Distressed Deal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... San Diego, CA (PRWEB) , ... April 24, ... ... of primary brain tumors are expected to be diagnosed globally; approximately 25,000 of ... healthcare professionals are anticipating greater use of this type of healthcare model in ...
(Date:4/24/2017)... ... April 24, 2017 , ... As a former supermodel known for her ... good news for single women is that she put all the words in her ... 25th. Joan's insight, personal experiences and sparkling sense of humor have inspired her to ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... countries clearly shows that over the last decade, student well-being has seriously declined. ... the boxes of formal education, join the Islamic State to turn the historic ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... PA will be attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium on Tissue ... Oral Reconstruction Foundation will present its annual Global Symposium at the Fontainebleau Hotel ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... and laboratory-grade deionized water from the same place. From 101 Water Texas, here ... Satisfaction: Patients and staff can enjoy a continuous supply of pure, fresh, oxygenated ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 The Global ... Forecast to 2022 report has covered and analysed the potential ... information on market size, shares and growth factors. The report ... challenges and opportunities in the global market. ... Browse 152 Tables and Figures, 6 Major ...
(Date:4/19/2017)... , April 19, 2017  New research provides evidence that ... Parkinson,s, according to a study released today that will be ... Meeting in Boston , April 22 ... the treatment of Parkinson,s disease, the oral drug levodopa has ... and longevity. But as the disease progresses, the effects of ...
(Date:4/18/2017)... April 18, 2017  Cardinal Health (NYSE: ... fiscal 2017 earnings per share (EPS) guidance and providing ... is in conjunction with this morning,s announcement of the ... and Nutritional Insufficiency businesses. Cardinal Health now ... will be at the bottom of its previous guidance ...
Breaking Medicine Technology: